Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;
10.1016/j.aohep.2024.101757
Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease
Eda Kaya; Eduardo Vilar-Gomez; Raj Vuppalanchi; Yusuf Yilmaz;
10.1016/j.aohep.2025.101907
Assessment of Metabolic dysfunction-associated steatotic liver disease, Alcohol-associated liver disease, and Metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population
Jorge Emilio Lira-Vera; Ángel Daniel-Santana Vargas; Gabriela Gutiérrez-Reyes; Oscar Morales-Gutiérrez; María de Fátima Higuera-de la Tijera; Diana Montemira-Orozco; Christian Hinojosa-Segura; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María de los Ángeles Lemus-Peña; Daniel Montes de Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; Y.L. Béjar-Ramírez; José Luis Pérez-Hernández;
10.1016/j.aohep.2025.102149